1. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study;Aggarwal;Lancet Infect Dis,2023
2. Efficacy and safety of nirmatrelvir/ritonavir (paxlovid) for COVID-19: a rapid review and meta-analysis;Amani;J Med Virol,2022
3. Nirmatrelvir–ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis;Cheema;J Med Virol,2023
4. Efficacy and safety of paxlovid for COVID-19: a meta-analysis;Zheng;J Infect,2023
5. Real-world effectiveness of nirmatrelvir/ritonavir use for COVID-19: a population-based cohort study in Ontario, Canada;Schwartz;medRxiv,2022